Comparison of bupropion, fluoxetine, and methylphenidate in cancer-related fatigue
Phase 2
Recruiting
- Conditions
- Cancer-related fatigue.
- Registration Number
- IRCT20180623040193N3
- Lead Sponsor
- Shahre-kord University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Definite diagnosis of cancer from at least 2 month ago
Patients are undergoing outpatient chemotherapy
Lack of metastasis
Lack of any chronic cardiac or respiratory diseases or diabetes mellitus
Lack of severe bone pain and balance problem
Hemoglobin= 10
Ability to read and write
Not receiving any type of treatment (drug or psychotherapy) for fatigue in the past
Not having leukemia
Lack of past history of any major psychiatric illnesses for which patient was hospitalized or medicated
Exclusion Criteria
Acute respiratory, cardiac or infectious diseases
Hemoglobin<10
Uncontrolled hypothyroidism
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fatigue score in Cancer Fatigue scale and Fatigue Visual Analogue scale. Timepoint: Before intervention, 1 month and 2 months after pharmacotherapy. Method of measurement: Cancer Fatigue scale, Fatigue Visual Analogue scale.
- Secondary Outcome Measures
Name Time Method The Quality of life score in European Organization for Research and treatment of cancer quality of life questionnaire. Timepoint: Before intervention, 1 month and 2 months after pharmacotherapy. Method of measurement: European Organization for Research and treatment of cancer quality of life questionnaire version 3.